Literature DB >> 2194896

c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma.

G C Burmer1, D S Levine, B G Kulander, R C Haggitt, C E Rubin, P S Rabinovitch.   

Abstract

Mutations in the first exon of the c-Ki-ras protooncogene were analyzed in carcinomas and dysplasias from patients with sporadic colon cancer and chronic ulcerative colitis by a combination of histological enrichment, cell sorting, polymerase catalyzed chain reaction, and direct sequencing. In contrast to sporadic colon carcinomas, where 52% (11 of 21) contained mutations in codon 12, only 1 of 28 samples of ulcerative colitis associated carcinoma or dysplasia contained a c-Ki-ras mutation, despite the presence of aneuploid cell populations. These results suggest that a different genetic pathway for tumor progression may exist between sporadic colon carcinoma and carcinomas arising in chronic ulcerative colitis.

Entities:  

Mesh:

Year:  1990        PMID: 2194896     DOI: 10.1016/0016-5085(90)91024-z

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  38 in total

1.  Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis.

Authors:  S N Andersen; T O Rognum; A Bakka; O P Clausen
Journal:  Mol Pathol       Date:  1998-12

2.  Integration of multiple signaling pathway activities resolves K-RAS/N-RAS mutation paradox in colon epithelial cell response to inflammatory cytokine stimulation.

Authors:  Pamela K Kreeger; Yufang Wang; Kevin M Haigis; Douglas A Lauffenburger
Journal:  Integr Biol (Camb)       Date:  2010-03-08       Impact factor: 2.192

Review 3.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

Review 4.  The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis.

Authors:  Margaret Cho; Janell Carter; Saul Harari; Zhiheng Pei
Journal:  Clin Lab Med       Date:  2014-09-15       Impact factor: 1.935

Review 5.  A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.

Authors:  Ian S Reynolds; Aobhlinn O'Toole; Joseph Deasy; Deborah A McNamara; John P Burke
Journal:  Int J Colorectal Dis       Date:  2017-01-11       Impact factor: 2.571

6.  Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis.

Authors:  C J van der Woude; H Moshage; M Homan; J H Kleibeuker; P L M Jansen; H van Dekken
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

7.  K-ras mutations in patients with early colorectal cancers.

Authors:  H J Andreyev; J V Tilsed; D Cunningham; S A Sampson; A R Norman; H J Schneider; P A Clarke
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

8.  Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium.

Authors:  S Fujii; T Fujimori; H Kawamata; J Takeda; K Kitajima; F Omotehara; T Kaihara; T Kusaka; K Ichikawa; Y Ohkura; Y Ono; J Imura; S Yamaoka; C Sakamoto; Y Ueda; T Chiba
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.

Authors:  P Chaubert; J Benhattar; E Saraga; J Costa
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

10.  Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease.

Authors:  R J Alexander; A Panja; E Kaplan-Liss; L Mayer; R F Raicht
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.